The Zero Negative Foundation

The Zero Negative Foundation is a 501(c)(3) nonprofit organization. Founders Jenn Greenhut, a stage IV triple-negative breast cancer survivor, and Stacey Uberstine, a stage II ER-positive survivor, have a clear mission: to honor patients by gifting them specially curated tote bags filled with personalized goodies to support them throughout their cancer treatment. ZNF believes in the power of love, gratitude, and trust as integral parts of the healing process, and is dedicated to making every patient feel loved and prayed for every step of the way. 

Your generous donations directly support the creation of our 'Chemo Love Totes,' meticulously crafted with wisdom and insights gleaned from Jenn and Stacey's personal journeys. These Love Totes serve as empowering companions, sharing the secrets of transforming a daunting diagnosis into a journey of growth and resilience. Each tote features personal tips from Jenn and Stacey, alongside cozy items designed to provide comfort and support during treatment. Additionally, they include a specially curated Spotify playlist for chemo rounds, practical essentials not readily available elsewhere, and a "Dear Cancer, Love Me" journal to encourage healing through self-expression.

Drawing from their own experiences, Jenn and Stacey deeply understand the profound impact of receiving love and support during challenging times. It's this transformative experience that motivates us to replicate through our Love Totes, reminding patients that they are cherished, loved, and never alone.

Furthermore, we are steadfast in our commitment to expanding our product line with items designed to spread love and gratitude, providing support to patients, caregivers, and survivors. Additionally, a portion of our proceeds goes towards funding cancer research at UCLA’s Jonsson Cancer Center Foundation. By partnering with us through your donations, you become an integral part of inspiring healing and empowering individuals to turn all negatives into positive life experiences.